QIAGEN Tests Clinically Verified for the Monitoring of Swine Flu

05-07-2009: Analyses performed by the German Bernhard Nocht Institute for Tropical Medicine have proven that the influenza A / H1N1 virus can be unequivocally detected using a screening test developed by QIAGEN. The company's artus Influenza LC RT PCR Kit was successfully used to screen a female patient who had come down with the disease in Mexico and is currently being treated at the Eppendorf University Hospital in Hamburg, Germany. The patient is currently one of the confirmed cases of swine flu in Germany.

Regulatory approval of the product for in-vitro diagnostic applications has not been sought yet by QIAGEN, but applications can be officially submitted on a short-term basis depending on the further proliferation of the disease.